How Can We Increase Model Utility for Combination Therapy?

Time: 2:40 pm
day: Day Two


  • How to select the right model to use? Is it a trial-and-error approach?
  • What did we learn from our clinical studies, and incorporate this into our preclinical programs? E.g. toxicity & dosing schedule
  • How to combat resistance mechanisms?